On Monday 21 December, the European Union granted a conditional marketing authorisation very soon to the Covid-19 vaccine called Comirnaty and marketed by the Pfizer/BioNTech alliance.
The decision follows a positive opinion issued earlier in the day by the European Medicines Agency (EMA). The President of the European Commission, Ursula von der Leyen, welcomed the fact that all Member States will have access to the doses “at the same time and under the same conditions”. This will...